Literature DB >> 16360363

Inflammatory markers and serum lipids in idiopathic dilated cardiomyopathy.

Tiziana Sampietro1, Danilo Neglia, Alberto Bionda, Beatrice Dal Pino, Federico Bigazzi, Mariarita Puntoni, Umberto Startari, Aurora Morales, Fabrizio Minichilli, Fabrizio Bianchi, Antonio L'Abbate.   

Abstract

Coronary microcirculation is impaired in idiopathic dilated cardiomyopathy (IDC), possibly because of endothelial dysfunction. High-density lipoproteins (HDLs) have the potential to regulate endothelial function and modulate inflammation and the innate immune response. This study investigated whether reduced HDLs, concomitantly with the activation of inflammation, are associated with IDC. Fifty-five patients with IDC, without evidence of other organ or systemic, chronic, or recurrent diseases, were compared with 55 healthy controls for HDLs and complete lipid profiles, C-reactive protein, C3 and C4 complement fractions, soluble intercellular adhesion molecule-1 and soluble endothelial leukocyte adhesion molecule-1, haptoglobin, and ceruloplasmin. Patients with IDC differed from controls, with lower HDL levels, lower apolipoprotein A-I and A-II levels, and higher triglyceride levels, but not on total and low-density lipoprotein cholesterol, apolipoprotein B, or lipoprotein(a). In addition, all measured inflammation markers were significantly greater in patients with IDC than in controls and were negatively correlated with HDLs. A strong and independent association with IDC was found for age, soluble intercellular adhesion molecule-1, and HDLs that, when categorized as <40 or >40 mg/dl, showed the strongest association (prevalence odds ratio 0.10, p <0.0005) with the disease. In conclusion, the data here reported on reduced HDLs and increased endothelial inflammatory activation and the linear negative correlation between HDLs and inflammation markers, particularly soluble intercellular adhesion molecule-1, could suggest a role for HDLs in the endothelial-microvascular dysfunction seen in IDC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16360363     DOI: 10.1016/j.amjcard.2005.07.093

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

1.  Insulin resistance is a major determinant of myocardial blood flow impairment in anginal patients.

Authors:  Riccardo Liga; Daniele Rovai; Tiziana Sampietro; Cecilia Vecoli; Giancarlo Todiere; Chiara Caselli; Giuseppe Rossi; Antonio L'abbate; Danilo Neglia
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-11       Impact factor: 9.236

2.  Abnormal glucose and lipid control in non-ischemic left ventricular dysfunction.

Authors:  Danilo Neglia; Tiziana Sampietro; Cecilia Vecoli; Riccardo Liga; Giuseppe Rossi; Elena Filidei; Federico Bigazzi; Patricia Iozzo; Daniela Giannessi; Antonio L'Abbate; Daniele Rovai
Journal:  J Nucl Cardiol       Date:  2012-08-10       Impact factor: 5.952

3.  Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure.

Authors:  Daniela Giannessi; Chiara Caselli; Silvia Del Ry; Maristella Maltinti; Silvia Pardini; Stefano Turchi; Manuela Cabiati; Tiziana Sampietro; Nader Abraham; Antonio L'abbate; Danilo Neglia
Journal:  Metabolism       Date:  2010-03-04       Impact factor: 8.694

4.  Cellular proliferative response to cardiac troponin-I in patients with idiopathic dilated cardiomyopathy.

Authors:  Jason M Lappé; Clara M Pelfrey; Anne Cotleur; Wai Hong Wilson Tang
Journal:  Clin Transl Sci       Date:  2011-10       Impact factor: 4.689

5.  Diminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failure.

Authors:  W H Wilson Tang; Yuping Wu; Shirley Mann; Michael Pepoy; Kevin Shrestha; Allen G Borowski; Stanley L Hazen
Journal:  Circ Heart Fail       Date:  2010-11-09       Impact factor: 8.790

Review 6.  Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy.

Authors:  Jason M Lappé; Clara M Pelfrey; W H Wilson Tang
Journal:  J Card Fail       Date:  2008-05-27       Impact factor: 5.712

7.  Comparison of biomarkers of oxidative stress and cardiovascular disease in humans and chimpanzees (Pan troglodytes).

Authors:  Elaine N Videan; Christopher B Heward; Kajal Chowdhury; John Plummer; Yali Su; Richard G Cutler
Journal:  Comp Med       Date:  2009-06       Impact factor: 0.982

8.  Circulating heat shock proteins and inflammatory markers in patients with idiopathic left ventricular dysfunction: their relationships with myocardial and microvascular impairment.

Authors:  Daniela Giannessi; Chiara Colotti; Maristella Maltinti; Silvia Del Ry; Concetta Prontera; Stefano Turchi; Antonio Labbate; Danilo Neglia
Journal:  Cell Stress Chaperones       Date:  2007       Impact factor: 3.667

9.  Systemic inflammation in nonischemic dilated cardiomyopathy.

Authors:  Luisa De Gennaro; Natale Daniele Brunetti; Andrea Cuculo; Pier Luigi Pellegrino; Matteo Di Biase
Journal:  Heart Vessels       Date:  2008-11-27       Impact factor: 2.037

10.  Increased plasma mannose binding lectin levels are associated with bronchiolitis obliterans after lung transplantation.

Authors:  Steven J Budd; Robert M Aris; Ayorinde A Medaiyese; Stephen L Tilley; Isabel P Neuringer
Journal:  Respir Res       Date:  2012-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.